Delivers Strong Quarter, Raises Full-Year Guidance
Highlights:
-
GAAP income from continuing operations of $91 million, or $0.28 per
share
-
Non-GAAP income from continuing operations of $145 million, or $0.44
per share(1)
-
Revenue of $1.02 billion; core revenue growth of 8.0 percent(2)
-
Raises fiscal year guidance for core revenue growth(2),
adjusted non-GAAP operating margin(3), non-GAAP earnings
per share(4) and operating cash flow
-
Fiscal year 2016 revenue guidance of $4.16 billion to $4.18 billion,
and non-GAAP earnings guidance of $1.88 to $1.92 per share(4)
SANTA CLARA, Calif.--(BUSINESS WIRE)--May 16, 2016--
Agilent Technologies Inc. (NYSE:A) today reported revenue of $1.02
billion, up 6 percent year over year (up 8 percent on a core basis(2))
for the second fiscal quarter ended April 30, 2016.
Second-quarter GAAP income from continuing operations was $91 million,
or $0.28 per share. Last year’s second-quarter GAAP income from
continuing operations was $92 million, or $0.27 per share.
During the second quarter, Agilent had intangible amortization of $40
million, transformation costs of $10 million, acquisition and
integration costs of $12 million, and $2 million of other costs.
Excluding those items, and a tax benefit of $10 million, Agilent
reported second-quarter adjusted income from continuing operations of
$145 million, $0.44 per share(1).
Agilent’s adjusted operating margin was 19.4 percent(3) for
the second quarter, up 110 basis points over a year ago.
“Agilent delivered another strong quarter,” said Mike McMullen, Agilent
president and CEO. “Revenue and earnings per share exceeded our guidance
range. We saw broad growth across most of our portfolio and end markets.”
“We continue to execute on our strategy to drive sustainable growth,
expand operating margins and provide long-term value to our
shareholders,” he added.
Second-quarter revenue of $495 million from Agilent’s Life Sciences and
Applied Markets Group (LSAG) increased 5 percent year over year (up 8
percent on a core basis(2)), led by strong growth in pharma,
food and environmental markets. LSAG’s Q2 operating margin was 19.0
percent.
Second-quarter revenue of $346 million from the Agilent CrossLab Group
(ACG) grew 8 percent year over year (up 10 percent on a core basis(2)).
Both services and consumables continued to see solid growth worldwide.
ACG’s operating margin was 21.5 percent for the quarter.
Second-quarter revenue of $178 million from Agilent’s Diagnostics and
Genomics Group (DGG) increased 5 percent against a tough year-over-year
compare (also up 5 percent on a core basis(2)), reflecting
strength in its diagnostics and genomics businesses. DGG’s operating
margin for the quarter was 15.0 percent.
Agilent expects third-quarter 2016 revenue in the range of $1.03 billion
to $1.05 billion. Third-quarter non-GAAP earnings are expected to be in
the range of $0.45 to $0.47 per share(4).
For fiscal year 2016, Agilent expects revenue of $4.16 billion to $4.18
billion and non-GAAP earnings of $1.88 to $1.92 per share(4).
The guidance is based on April 29, 2016 exchange rates.
Agilent is also raising its full-year operating cash flow guidance from
$650 million to $740 million. There is no change to the capital
expenditure guidance of $140 million.
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A), a global leader in life sciences,
diagnostics and applied chemical markets, is the premier laboratory
partner for a better world. Agilent works with customers in more than
100 countries, providing instruments, software, services and consumables
for the entire laboratory workflow. Agilent generated revenue of $4.04
billion in fiscal 2015. The company employs about 12,000 people
worldwide. Information about Agilent is available at www.agilent.com.
Agilent’s management will present more details about its second-quarter
FY2016 financial results on a conference call with investors today at
1:30 p.m. PT. This event will be webcast live in listen-only mode.
Listeners may log on at www.investor.agilent.com
and select “Q2 2016 Agilent Technologies Inc. Earnings Conference Call”
in the “News & Events Calendar of Events” section. The webcast will
remain available on the company’s website for 90 days.
Additional information regarding financial results can be found at www.investor.agilent.com
by selecting “Financial Results” in the “Financial Information” section.
A telephone replay of the conference call will be available at
approximately 4:30 p.m. PT today through May 23 by dialing +1 855 859
2056 (or +1 404 537 3406 from outside the United States) and entering
passcode 93209349.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the
Securities Exchange Act of 1934 and is subject to the safe harbors
created therein. The forward-looking statements contained herein
include, but are not limited to, information regarding Agilent’s future
revenue, earnings and profitability; planned new products; market
trends; the future demand for the company’s products and services;
customer expectations; and revenue and non-GAAP earnings guidance for
the third quarter and full fiscal year 2016. These forward-looking
statements involve risks and uncertainties that could cause Agilent’s
results to differ materially from management’s current expectations.
Such risks and uncertainties include, but are not limited to, unforeseen
changes in the strength of our customers’ businesses; unforeseen changes
in the demand for current and new products, technologies, and services;
unforeseen changes in the currency markets; customer purchasing
decisions and timing, and the risk that we are not able to realize the
savings expected from integration and restructuring activities.
In addition, other risks that Agilent faces in running its operations
include the ability to execute successfully through business cycles; the
ability to meet and achieve the benefits of its cost-reduction goals and
otherwise successfully adapt its cost structures to continuing changes
in business conditions; ongoing competitive, pricing and gross-margin
pressures; the risk that our cost-cutting initiatives will impair our
ability to develop products and remain competitive and to operate
effectively; the impact of geopolitical uncertainties and global
economic conditions on our operations, our markets and our ability to
conduct business; the ability to improve asset performance to adapt to
changes in demand; the ability of our supply chain to adapt to changes
in demand; the ability to successfully introduce new products at the
right time, price and mix; the ability of Agilent to successfully
integrate recent acquisitions; the ability of Agilent to successfully
comply with certain complex regulations; and other risks detailed in
Agilent’s filings with the Securities and Exchange Commission, including
our quarterly report on Form 10-Q for the quarter ended Jan. 31, 2016.
Forward-looking statements are based on the beliefs and assumptions of
Agilent’s management and on currently available information. Agilent
undertakes no responsibility to publicly update or revise any
forward-looking statement.
|
|
|
(1)
|
Non-GAAP income from continuing operations and non-GAAP income from
continuing operations per share exclude primarily the impacts of
acquisition and integration costs, transformation initiatives,
business exit and divestiture costs, and non-cash intangibles
amortization. We also exclude any tax benefits that are not directly
related to ongoing operations and which are either isolated or
cannot be expected to occur again with any regularity or
predictability. A reconciliation between non-GAAP income from
continuing operations and GAAP income from continuing operations is
set forth on page 6 of the attached tables along with additional
information regarding the use of this non-GAAP measure.
|
|
|
|
(2)
|
Core revenue growth excludes the impact of currency, the NMR
business and acquisitions and divestitures within the past 12
months. Core revenue is a non-GAAP measure. Core revenue growth as
projected for the full fiscal year 2016 excludes amounts pertaining
to events that have not yet occurred and are not currently possible
to estimate with a reasonable degree of accuracy. A reconciliation
between Q2 FY16 GAAP revenue and core revenue is set forth on page 8
of the attached tables along with additional information regarding
the use of this non-GAAP measure.
|
|
|
|
(3)
|
Adjusted non-GAAP operating margin is a non-GAAP measure and
excludes primarily the impacts of acquisition and integration costs,
transformation initiatives, business exit and divestiture costs, and
non-cash intangibles amortization in addition to the costs related
to services that Agilent is providing to Keysight post separation.
Adjusted non-GAAP operating margin as projected for the full fiscal
year 2016 excludes amounts pertaining to events that have not yet
occurred and are not currently possible to estimate with a
reasonable degree of accuracy. A reconciliation for Q2 FY16 is set
forth on page 9 of the attached tables along with additional
information regarding the use of this non-GAAP measure.
|
|
|
|
(4)
|
Non-GAAP earnings per share as projected for Q3 FY16 and full fiscal
year 2016 excludes primarily the future impact of acquisition and
integration costs, pension curtailment gain, business exit and
divestiture costs and non-cash intangibles amortization. We also
exclude any tax benefits that are not directly related to ongoing
operations and which are either isolated or cannot be expected to
occur again with any regularity or predictability. Most of these
excluded amounts pertain to events that have not yet occurred and
are not currently possible to estimate with a reasonable degree of
accuracy. Therefore, no reconciliation to GAAP amounts has been
provided. Future amortization of intangibles is expected to be
approximately $38 million per quarter.
|
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available on the Agilent news site at www.agilent.com/go/news.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
|
|
(In millions, except per share amounts)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
|
|
|
April 30,
|
|
|
Percent
|
|
|
|
|
|
2016
|
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
(As Revised)
|
|
|
Inc/(Dec)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue
|
|
|
|
$
|
1,019
|
|
|
|
|
$
|
963
|
|
|
|
|
6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products and services
|
|
|
|
|
489
|
|
|
|
|
|
483
|
|
|
|
|
1%
|
|
Research and development
|
|
|
|
|
81
|
|
|
|
|
|
81
|
|
|
|
|
—
|
|
Selling, general and administrative
|
|
|
|
|
318
|
|
|
|
|
|
292
|
|
|
|
|
9%
|
|
Total costs and expenses
|
|
|
|
|
888
|
|
|
|
|
|
856
|
|
|
|
|
4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
|
|
131
|
|
|
|
|
|
107
|
|
|
|
|
22%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
|
|
3
|
|
|
|
|
|
2
|
|
|
|
|
50%
|
|
Interest expense
|
|
|
|
|
(18
|
)
|
|
|
|
|
(17
|
)
|
|
|
|
6%
|
|
Other income (expense), net
|
|
|
|
|
1
|
|
|
|
|
|
4
|
|
|
|
|
(75%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before taxes
|
|
|
|
|
117
|
|
|
|
|
|
96
|
|
|
|
|
22%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
|
|
26
|
|
|
|
|
|
4
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
|
91
|
|
|
|
|
|
92
|
|
|
|
|
(1%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, net of tax
|
|
|
|
|
-
|
|
|
|
|
|
(5
|
)
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
$
|
91
|
|
|
|
|
$
|
87
|
|
|
|
|
5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share - Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
$
|
0.28
|
|
|
|
|
$
|
0.28
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
|
|
$
|
-
|
|
|
|
|
$
|
(0.02
|
)
|
|
|
|
|
|
Net income per share - Basic
|
|
|
|
$
|
0.28
|
|
|
|
|
$
|
0.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share - Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
$
|
0.28
|
|
|
|
|
$
|
0.27
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
|
|
$
|
-
|
|
|
|
|
$
|
(0.01
|
)
|
|
|
|
|
|
Net income per share - Diluted
|
|
|
|
$
|
0.28
|
|
|
|
|
$
|
0.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in computing net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
326
|
|
|
|
|
|
334
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
328
|
|
|
|
|
|
337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per common share
|
|
|
|
$
|
0.115
|
|
|
|
|
$
|
0.100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The preliminary income statement is estimated based on our current
information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
|
|
(In millions, except per share amounts)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
|
|
|
|
|
April 30,
|
|
|
Percent
|
|
|
|
|
|
2016
|
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
(As Revised)
|
|
|
Inc/(Dec)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue
|
|
|
|
$
|
2,047
|
|
|
|
|
$
|
1,989
|
|
|
|
|
3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products and services
|
|
|
|
|
980
|
|
|
|
|
|
996
|
|
|
|
|
(2%)
|
|
Research and development
|
|
|
|
|
159
|
|
|
|
|
|
169
|
|
|
|
|
(6%)
|
|
Selling, general and administrative
|
|
|
|
|
622
|
|
|
|
|
|
602
|
|
|
|
|
3%
|
|
Total costs and expenses
|
|
|
|
|
1,761
|
|
|
|
|
|
1,767
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
|
|
286
|
|
|
|
|
|
222
|
|
|
|
|
29%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
|
|
5
|
|
|
|
|
|
4
|
|
|
|
|
25%
|
|
Interest expense
|
|
|
|
|
(36
|
)
|
|
|
|
|
(33
|
)
|
|
|
|
9%
|
|
Other income (expense), net
|
|
|
|
|
4
|
|
|
|
|
|
16
|
|
|
|
|
(75%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before taxes
|
|
|
|
|
259
|
|
|
|
|
|
209
|
|
|
|
|
24%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
|
|
45
|
|
|
|
|
|
24
|
|
|
|
|
88%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
|
214
|
|
|
|
|
|
185
|
|
|
|
|
16%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, net of tax
|
|
|
|
|
-
|
|
|
|
|
|
(35
|
)
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
$
|
214
|
|
|
|
|
$
|
150
|
|
|
|
|
43%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share - Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
$
|
0.65
|
|
|
|
|
$
|
0.55
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
|
|
$
|
-
|
|
|
|
|
$
|
(0.10
|
)
|
|
|
|
|
|
Net income per share - Basic
|
|
|
|
$
|
0.65
|
|
|
|
|
$
|
0.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share - Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
$
|
0.65
|
|
|
|
|
$
|
0.55
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
|
|
$
|
-
|
|
|
|
|
$
|
(0.10
|
)
|
|
|
|
|
|
Net income per share - Diluted
|
|
|
|
$
|
0.65
|
|
|
|
|
$
|
0.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in computing net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
327
|
|
|
|
|
|
335
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
330
|
|
|
|
|
|
337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per common share
|
|
|
|
$
|
0.230
|
|
|
|
|
$
|
0.200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The preliminary income statement is estimated based on our current
information.
|
|
|
|
|
|
|
|
|
|
|
Page 2
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
|
|
(In millions)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
|
|
|
April 30,
|
|
April 30,
|
|
|
|
|
|
2016
|
|
|
2015
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
(As Revised)
|
|
|
|
|
(As Revised)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
$
|
91
|
|
|
|
$
|
87
|
|
|
|
$
|
214
|
|
|
|
$
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on derivative instruments
|
|
|
|
|
(9
|
)
|
|
|
|
(1
|
)
|
|
|
|
(6
|
)
|
|
|
|
6
|
|
|
Amounts reclassified into earnings related to derivative instruments
|
|
|
|
|
-
|
|
|
|
|
(5
|
)
|
|
|
|
(1
|
)
|
|
|
|
(8
|
)
|
|
Foreign currency translation
|
|
|
|
|
145
|
|
|
|
|
(6
|
)
|
|
|
|
89
|
|
|
|
|
(271
|
)
|
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in actuarial net loss
|
|
|
|
|
6
|
|
|
|
|
6
|
|
|
|
|
21
|
|
|
|
|
10
|
|
|
Change in net prior service benefit
|
|
|
|
|
(3
|
)
|
|
|
|
(3
|
)
|
|
|
|
(11
|
)
|
|
|
|
(5
|
)
|
|
Other comprehensive income (loss)
|
|
|
|
|
139
|
|
|
|
|
(9
|
)
|
|
|
|
92
|
|
|
|
|
(268
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
|
|
$
|
230
|
|
|
|
$
|
78
|
|
|
|
$
|
306
|
|
|
|
$
|
(118
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The preliminary statement of comprehensive income is estimated based
on our current information.
|
|
|
Page 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
|
(In millions, except par value and share amounts)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30,
|
|
|
October 31,
|
|
|
|
|
|
2016
|
|
|
2015
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
$
|
2,139
|
|
|
|
$
|
2,003
|
|
|
Short-term restricted cash and cash equivalents
|
|
|
|
|
—
|
|
|
|
|
242
|
|
|
Accounts receivable, net
|
|
|
|
|
602
|
|
|
|
|
606
|
|
|
Inventory
|
|
|
|
|
555
|
|
|
|
|
541
|
|
|
Other current assets
|
|
|
|
|
192
|
|
|
|
|
294
|
|
|
Total current assets
|
|
|
|
|
3,488
|
|
|
|
|
3,686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
610
|
|
|
|
|
604
|
|
|
Goodwill
|
|
|
|
|
2,556
|
|
|
|
|
2,366
|
|
|
Other intangible assets, net
|
|
|
|
|
490
|
|
|
|
|
445
|
|
|
Long-term investments
|
|
|
|
|
157
|
|
|
|
|
86
|
|
|
Other assets
|
|
|
|
|
339
|
|
|
|
|
292
|
|
|
Total assets
|
|
|
|
$
|
7,640
|
|
|
|
$
|
7,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
|
$
|
220
|
|
|
|
$
|
279
|
|
|
Employee compensation and benefits
|
|
|
|
|
211
|
|
|
|
|
221
|
|
|
Deferred revenue
|
|
|
|
|
279
|
|
|
|
|
258
|
|
|
Short-term debt
|
|
|
|
|
235
|
|
|
|
|
—
|
|
|
Other accrued liabilities
|
|
|
|
|
188
|
|
|
|
|
218
|
|
|
Total current liabilities
|
|
|
|
|
1,133
|
|
|
|
|
976
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
|
|
1,654
|
|
|
|
|
1,655
|
|
|
Retirement and post-retirement benefits
|
|
|
|
|
242
|
|
|
|
|
264
|
|
|
Other long-term liabilities
|
|
|
|
|
446
|
|
|
|
|
414
|
|
|
Total liabilities
|
|
|
|
|
3,475
|
|
|
|
|
3,309
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock; $0.01 par value; 125 million shares authorized;
none issued and outstanding
|
|
|
|
|
—
|
|
|
|
|
—
|
|
|
Common stock; $0.01 par value, 2 billion shares authorized; 612
million shares at April 30, 2016 and 611 million shares at October
31, 2015, issued
|
|
|
|
|
6
|
|
|
|
|
6
|
|
|
Treasury stock at cost; 287 million shares at April 30, 2016 and
279 million shares at October 31, 2015
|
|
|
|
|
(10,368
|
)
|
|
|
|
(10,074
|
)
|
|
Additional paid-in-capital
|
|
|
|
|
9,103
|
|
|
|
|
9,045
|
|
|
Retained earnings
|
|
|
|
|
5,720
|
|
|
|
|
5,581
|
|
|
Accumulated other comprehensive loss
|
|
|
|
|
(299
|
)
|
|
|
|
(391
|
)
|
|
Total stockholders' equity
|
|
|
|
|
4,162
|
|
|
|
|
4,167
|
|
|
Non-controlling interest
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
Total equity
|
|
|
|
|
4,165
|
|
|
|
|
4,170
|
|
|
Total liabilities and equity
|
|
|
|
$
|
7,640
|
|
|
|
$
|
7,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The preliminary balance sheet is estimated based on our current
information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page 4
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
|
|
(In millions)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Six Months
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
|
|
|
April 30,
|
|
|
April 30,
|
|
|
|
|
|
2016
|
|
|
2016
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
$
|
91
|
|
|
|
$
|
214
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile net income to net cash provided by (used
in) operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
64
|
|
|
|
|
130
|
|
|
Share-based compensation
|
|
|
|
|
13
|
|
|
|
|
36
|
|
|
Excess tax benefit from share-based plans
|
|
|
|
|
2
|
|
|
|
|
—
|
|
|
Excess and obsolete inventory related charges
|
|
|
|
|
8
|
|
|
|
|
12
|
|
|
Other non-cash expenses, net
|
|
|
|
|
6
|
|
|
|
|
8
|
|
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
|
|
34
|
|
|
|
|
19
|
|
|
Inventory
|
|
|
|
|
—
|
|
|
|
|
(13
|
)
|
|
Accounts payable
|
|
|
|
|
(35
|
)
|
|
|
|
(53
|
)
|
|
Employee compensation and benefits
|
|
|
|
|
34
|
|
|
|
|
(13
|
)
|
|
Other assets and liabilities
|
|
|
|
|
39
|
|
|
|
|
20
|
|
|
Net cash provided by operating activities (a) |
|
|
|
|
256
|
|
|
|
|
360
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Investments in property, plant and equipment
|
|
|
|
|
(25
|
)
|
|
|
|
(63
|
)
|
|
Proceeds from sale of investment securities
|
|
|
|
|
—
|
|
|
|
|
1
|
|
|
Payment to acquire Lasergen investment
|
|
|
|
|
(80
|
)
|
|
|
|
(80
|
)
|
|
Loan to equity method investment
|
|
|
|
|
(3
|
)
|
|
|
|
(3
|
)
|
|
Change in restricted cash and cash equivalents, net
|
|
|
|
|
—
|
|
|
|
|
245
|
|
|
Payment in exchange for convertible loan
|
|
|
|
|
—
|
|
|
|
|
(1
|
)
|
|
Acquisition of businesses and intangible assets, net of cash acquired
|
|
|
|
|
—
|
|
|
|
|
(235
|
)
|
|
Net cash used in investing activities
|
|
|
|
|
(108
|
)
|
|
|
|
(136
|
)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Issuance of common stock under employee stock plans
|
|
|
|
|
8
|
|
|
|
|
32
|
|
|
Treasury stock repurchases
|
|
|
|
|
(94
|
)
|
|
|
|
(294
|
)
|
|
Payment of dividends
|
|
|
|
|
(37
|
)
|
|
|
|
(75
|
)
|
|
Proceeds from revolving credit facility
|
|
|
|
|
155
|
|
|
|
|
255
|
|
|
Repayment of revolving credit facility
|
|
|
|
|
—
|
|
|
|
|
(20
|
)
|
|
Excess tax benefit from share-based plans
|
|
|
|
|
(2
|
)
|
|
|
|
—
|
|
|
Net cash provided by (used in) financing activities
|
|
|
|
|
30
|
|
|
|
|
(102
|
)
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate movements
|
|
|
|
|
30
|
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
|
|
208
|
|
|
|
|
136
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
1,931
|
|
|
|
|
2,003
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
|
|
$
|
2,139
|
|
|
|
$
|
2,139
|
|
|
|
|
|
|
|
|
|
|
|
(a) Cash payments included in operating activities:
|
|
|
|
|
|
|
|
|
Severance payments
|
|
|
|
|
1
|
|
|
|
|
3
|
|
|
Income tax payments (refunds), net
|
|
|
|
|
(16
|
)
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The preliminary cash flow is estimated based on our current
information.
|
|
|
Page 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
NON-GAAP INCOME FROM CONTINUING OPERATIONS AND DILUTED EPS
RECONCILIATIONS
|
|
(In millions, except per share amounts)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
|
|
|
April 30,
|
|
April 30,
|
|
|
|
|
|
|
|
Diluted
|
|
|
|
Diluted
|
|
|
|
Diluted
|
|
|
|
Diluted
|
|
|
|
|
|
2016
|
|
EPS
|
|
2015
|
|
EPS
|
|
2016
|
|
EPS
|
|
2015
|
|
EPS
|
|
|
|
|
|
|
|
|
|
|
(As Revised)
|
|
|
|
|
|
|
|
(As Revised)
|
|
GAAP Income from continuing operations
|
|
|
|
$
|
91
|
|
|
$
|
0.28
|
|
|
|
$
|
92
|
|
|
|
0.27
|
|
|
|
$
|
214
|
|
|
$
|
0.65
|
|
|
|
$
|
185
|
|
|
|
0.55
|
|
|
Non-GAAP adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acceleration of share-based compensation related to workforce
reduction
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
1
|
|
|
|
—
|
|
|
|
|
-
|
|
|
|
—
|
|
|
|
|
2
|
|
|
|
0.01
|
|
|
Intangible amortization
|
|
|
|
|
40
|
|
|
|
0.12
|
|
|
|
|
38
|
|
|
|
0.11
|
|
|
|
|
83
|
|
|
|
0.25
|
|
|
|
|
81
|
|
|
|
0.24
|
|
|
Business exit and divestiture costs
|
|
|
|
|
1
|
|
|
|
—
|
|
|
|
|
10
|
|
|
|
0.03
|
|
|
|
|
5
|
|
|
|
0.02
|
|
|
|
|
13
|
|
|
|
0.04
|
|
|
Transformational initiatives
|
|
|
|
|
10
|
|
|
|
0.03
|
|
|
|
|
17
|
|
|
|
0.05
|
|
|
|
|
21
|
|
|
|
0.06
|
|
|
|
|
29
|
|
|
|
0.09
|
|
|
Acquisition and integration costs
|
|
|
|
|
12
|
|
|
|
0.04
|
|
|
|
|
1
|
|
|
|
—
|
|
|
|
|
17
|
|
|
|
0.05
|
|
|
|
|
2
|
|
|
|
0.01
|
|
|
Pension curtailment gain
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
(16
|
)
|
|
|
(0.05
|
)
|
|
|
|
—
|
|
|
|
—
|
|
|
Other
|
|
|
|
|
1
|
|
|
|
—
|
|
|
|
|
(2
|
)
|
|
|
(0.01
|
)
|
|
|
|
3
|
|
|
|
0.01
|
|
|
|
|
(1
|
)
|
|
|
—
|
|
|
Adjustment for taxes (a) |
|
|
|
|
(10
|
)
|
|
|
(0.03
|
)
|
|
|
|
(28
|
)
|
|
|
(0.07
|
)
|
|
|
|
(29
|
)
|
|
|
(0.09
|
)
|
|
|
|
(43
|
)
|
|
|
(0.14
|
)
|
|
Non-GAAP Income from continuing operations
|
|
|
|
$
|
145
|
|
|
$
|
0.44
|
|
|
|
$
|
129
|
|
|
$
|
0.38
|
|
|
|
$
|
298
|
|
|
$
|
0.90
|
|
|
|
$
|
268
|
|
|
$
|
0.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) The adjustment for taxes excludes tax benefits that
management believes are not directly related to ongoing operations
and which are either isolated or cannot be expected to occur again
with any regularity or predictability. For the three and six months
ended April 30, 2016 and 2015 , management uses a non-GAAP effective
tax rate of 20% for both periods, that we believe to be indicative
of on-going operations.
|
|
|
|
|
Historical amounts are reclassified to conform with current
presentation.
|
|
|
|
|
We provide non-GAAP income from continuing operations and non-GAAP
income from continuing operations per share amounts in order to
provide meaningful supplemental information regarding our
operational performance and our prospects for the future. These
supplemental measures exclude, among other things, charges related
to the amortization of intangibles, pension curtailment,
transformational initiatives, acquisition and integration costs and
business exit and divestiture costs.
|
|
|
|
Business exit and divestiture costs include costs associated
with the exit of the NMR business and the divestiture of the XRD
business.
|
|
|
|
Transformational initiatives include expenses associated with
targeted cost reduction activities such as manufacturing transfers,
small site consolidations, reorganizations, insourcing or
outsourcing of activities. Such costs may include move and
relocation costs, one-time termination benefits and other one-time
reorganization costs. Included in this category are also expenses
associated with the post-separation resizing of the IT
infrastructure and streamlining of IT systems as well as the
expenses incurred primarily in fiscal year 2015 to effect the Agile
Agilent reengineering.
|
|
|
|
Acquisition and Integration costs include all incremental
expenses incurred to effect a business combination. Such acquisition
costs may include advisory, legal, accounting, valuation, and other
professional or consulting fees. Such integration costs may include
expenses directly related to integration of business and facility
operations, information technology systems and infrastructure and
other employee-related costs.
|
|
|
|
Pension curtailment gain resulted from certain retirement
plans benefit reductions.
|
|
|
|
Other includes certain legal costs and settlements in
addition to other miscellaneous adjustments.
|
|
|
|
|
Our management uses non-GAAP measures to evaluate the performance of
our core businesses, to estimate future core performance and to
compensate employees. Since management finds this measure to be
useful, we believe that our investors benefit from seeing our
results “through the eyes” of management in addition to seeing our
GAAP results. This information facilitates our management’s internal
comparisons to our historical operating results as well as to the
operating results of our competitors.
|
|
|
|
|
Our management recognizes that items such as amortization of
intangibles can have a material impact on our cash flows and/or our
net income. Our GAAP financial statements including our statement of
cash flows portray those effects. Although we believe it is useful
for investors to see core performance free of special items,
investors should understand that the excluded items are actual
expenses that may impact the cash available to us for other uses. To
gain a complete picture of all effects on the company’s profit and
loss from any and all events, management does (and investors should)
rely upon the GAAP income statement. The non-GAAP numbers focus
instead upon the core business of the company, which is only a
subset, albeit a critical one, of the company’s performance.
|
|
|
|
|
Readers are reminded that non-GAAP numbers are merely a supplement
to, and not a replacement for, GAAP financial measures. They should
be read in conjunction with the GAAP financial measures. It should
be noted as well that our non-GAAP information may be different from
the non-GAAP information provided by other companies.
|
|
|
|
|
The preliminary non-GAAP net income and diluted EPS reconciliation
is estimated based on our current information.
|
|
|
Page 6
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
SEGMENT INFORMATION
|
|
(In millions, except where noted)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
Life Sciences and Applied Markets Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q2'16
|
|
|
Q2'15
|
|
Revenue
|
|
|
|
|
|
$
|
495
|
|
|
$
|
473
|
|
Gross Margin, %
|
|
|
|
|
|
|
58.5%
|
|
|
|
56.1%
|
|
Income from Operations
|
|
|
|
|
|
$
|
94
|
|
|
$
|
75
|
|
Operating margin, %
|
|
|
|
|
|
|
19.0%
|
|
|
|
15.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and Genomics Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q2'16
|
|
|
Q2'15
|
|
Revenue
|
|
|
|
|
|
$
|
178
|
|
|
$
|
169
|
|
Gross Margin, %
|
|
|
|
|
|
|
54.1%
|
|
|
|
54.8%
|
|
Income from Operations
|
|
|
|
|
|
$
|
27
|
|
|
$
|
25
|
|
Operating margin, %
|
|
|
|
|
|
|
15.0%
|
|
|
|
15.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agilent CrossLab Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q2'16
|
|
|
Q2'15
|
|
Revenue
|
|
|
|
|
|
$
|
346
|
|
|
$
|
321
|
|
Gross Margin, %
|
|
|
|
|
|
|
49.3%
|
|
|
|
49.6%
|
|
Income from Operations
|
|
|
|
|
|
$
|
74
|
|
|
$
|
69
|
|
Operating margin, %
|
|
|
|
|
|
|
21.5%
|
|
|
|
21.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations reflect the results of our reportable
segments under Agilent's management reporting system which are not
necessarily in conformity with GAAP financial measures. Income from
operations of our reporting segments exclude, among other things,
charges related to the amortization of intangibles, pension
curtailment gain, transformational initiatives, acquisition and
integration costs and business exit and divestiture costs.
|
|
|
|
Readers are reminded that non-GAAP numbers are merely a supplement
to, and not a replacement for, GAAP financial measures. They should
be read in conjunction with the GAAP financial measures. It should
be noted as well that our non-GAAP information may be different from
the non-GAAP information provided by other companies.
|
|
|
|
The preliminary segment information is estimated based on our
current information.
|
|
|
Page 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
RECONCILIATIONS OF REVENUE BY SEGMENT EXCLUDING THE NMR BUSINESS,
|
|
ACQUISITIONS, DIVESTITURES AND THE IMPACT OF CURRENCY ADJUSTMENTS
(CORE)
|
|
(in millions)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year-over-Year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year-over-Year
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Revenue by Segment
|
|
|
Q2'16
|
|
Q2'15
|
|
% Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life Sciences and Applied Markets Group
|
|
|
$
|
495
|
|
$
|
473
|
|
5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and Genomics Group
|
|
|
|
178
|
|
|
169
|
|
5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agilent CrossLab Group
|
|
|
|
346
|
|
|
321
|
|
8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agilent
|
|
|
$
|
1,019
|
|
$
|
963
|
|
6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency
|
|
|
|
|
|
|
Non-GAAP
|
|
|
Adjustments
|
|
Currency-Adjusted ((a))
|
|
|
|
|
|
|
|
|
Year-over-Year
|
|
|
|
|
|
|
|
|
|
Year-over-Year
|
|
Non GAAP Revenue by Segment
|
|
|
Q2'16
|
|
Q2'15
|
|
% Change
|
|
|
Q2'16
|
|
Q2'16
|
|
Q2'15
|
|
% Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life Sciences and Applied Markets Group excluding acquisition and NMR
|
|
|
$
|
484
|
|
$
|
453
|
|
7
|
%
|
|
|
$
|
(6
|
)
|
|
|
$
|
490
|
|
$
|
453
|
|
8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and Genomics Group excluding acquisition
|
|
|
|
177
|
|
|
169
|
|
4
|
%
|
|
|
|
(1
|
)
|
|
|
|
178
|
|
|
169
|
|
5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agilent CrossLab Group
|
|
|
|
346
|
|
|
321
|
|
8
|
%
|
|
|
|
(6
|
)
|
|
|
|
352
|
|
|
321
|
|
10
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agilent Revenue (Core)
|
|
|
$
|
1,007
|
|
$
|
943
|
|
7
|
%
|
|
|
$
|
(13
|
)
|
|
|
$
|
1,020
|
|
$
|
943
|
|
8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) We compare the year-over-year change in revenue
excluding the effect of the NMR business, recent acquisitions and
divestitures and foreign currency rate fluctuations to assess the
performance of our underlying business. To determine the impact of
currency fluctuations, current period results for entities reporting
in currencies other than United States dollars are converted into
United States dollars at the actual exchange rate in effect during
the respective prior periods.
|
|
|
|
|
The preliminary reconciliation of GAAP revenue adjusted for the NMR
business, recent acquisitions and divestitures and impact of
currency is estimated based on our current information.
|
|
|
Page 8
|
|
|
|
|
|
|
|
|
|
AGILENT TECHNOLOGIES, INC.
|
|
RECONCILIATION OF ADJUSTED NON-GAAP INCOME FROM OPERATIONS AND
OPERATING MARGINS
|
|
(In millions, except margin data)
|
|
(Unaudited)
|
|
PRELIMINARY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
|
|
|
|
|
|
Q2 2016
|
|
|
Margin %
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
$
|
1,019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations:
|
|
|
|
|
|
|
|
|
GAAP Income from operations
|
|
|
|
$
|
131
|
|
|
12.9
|
%
|
|
Add:
|
|
|
|
|
|
|
|
|
Intangible amortization
|
|
|
|
|
40
|
|
|
|
|
Transformational initiatives
|
|
|
|
|
10
|
|
|
|
|
Acquisition and integration costs
|
|
|
|
|
12
|
|
|
|
|
Business exit and divestiture costs
|
|
|
|
|
1
|
|
|
|
|
Other
|
|
|
|
|
1
|
|
|
|
|
Non-GAAP income from operations
|
|
|
|
$
|
195
|
|
|
19.1
|
%
|
|
Reimbursement from Keysight for services (a) |
|
|
|
|
3
|
|
|
|
|
Adjusted non-GAAP income from operations
|
|
|
|
$
|
198
|
|
|
19.4
|
%
|
|
(a) Post separation, Agilent is providing Keysight Technologies,
Inc. certain site services. These site services are included in our
operating expenses. The amounts billed to Keysight for these
services are recorded in other income.
|
|
|
|
|
We provide non-GAAP income from operations in order to provide
meaningful supplemental information regarding our operational
performance and our prospects for the future. These supplemental
measures exclude, among other things, charges related to the
amortization of intangibles, transformational initiatives,
acquisition and integration costs and business exit and divestiture
costs.
|
|
|
|
|
Our management recognizes that items such as amortization of
intangibles can have a material impact on our cash flows and/or our
net income. Our GAAP financial statements including our statement of
cash flows portray those effects. Although we believe it is useful
for investors to see core performance free of special items,
investors should understand that the excluded items are actual
expenses that may impact the cash available to us for other uses. To
gain a complete picture of all effects on the company’s profit and
loss from any and all events, management does (and investors should)
rely upon the GAAP income statement. The non-GAAP numbers focus
instead upon the core business of the company, which is only a
subset, albeit a critical one, of the company’s performance.
|
|
|
|
|
Readers are reminded that non-GAAP numbers are merely a supplement
to, and not a replacement for, GAAP financial measures. They should
be read in conjunction with the GAAP financial measures. It should
be noted as well that our non-GAAP information may be different from
the non-GAAP information provided by other companies.
|
|
|
|
|
The preliminary reconciliation of income from operations and
operating margins is estimated based on our current information.
|
|
|
Page 9

View source version on businesswire.com: http://www.businesswire.com/news/home/20160516006363/en/
Source: Agilent Technologies Inc.
Agilent Technologies Inc.
EDITORIAL CONTACT:
Russell Lee,
+1-408-345-8419
russell_lee@agilent.com
INVESTOR
CONTACT:
Alicia Rodriguez, +1-408-345-8948
alicia_rodriguez@agilent.com